Actively Recruiting
The Effect of Coconut Oil on Alopecia in Women Receiving Doxorubicin-Cycylophosphamide Treatment for Breast Cancer
Led by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Updated on 2025-02-12
86
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
D
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead Sponsor
Ç
Çankırı Karatekin University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate the effect of coconut oil on alopecia in women with breast cancer receiving chemotherapy. Alopecia, or hair loss, is a common side effect of cancer treatment, especially chemotherapy, which can damage hair follicles and cause hair to break or fall out. The study focuses on 86 female breast cancer patients treated with the Doxorubicin-Cyclophosphamide chemotherapy protocol. Participants will be divided into two groups: an experimental group and a control group. The experimental group will apply 10 milliliters of coconut oil to their hair follicles once a week, with weekly assessments of hair loss using alopecia evaluation scales. The control group will not apply any products to their hair but will also have their hair loss monitored weekly. The study period runs from February 1, 2025, to December 31, 2025. During the study, participants will complete an initial information form about their demographics and disease before starting chemotherapy. Weekly evaluations will use the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) to measure alopecia over 12 weeks. The study is randomized with single blinding and will monitor hair loss progression throughout treatment, aiming to better understand coconut oil's potential role in managing chemotherapy-induced alopecia.
CONDITIONS
Brief Title
The Effect of Coconut Oil on Alopecia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with breast cancer
- Scheduled for chemotherapy using the Doxorubicin-Cyclophosphamide protocol
- Volunteer to participate in the study
- Female
- 18 years of age or older and up to 65 years old
You will not qualify if you...
- Having any health problem or disability that prevents communication (such as vision, hearing, neurological, or psychiatric diseases)
- Planning treatments other than the Doxorubicin-Cyclophosphamide protocol for breast cancer
- Not volunteering to participate in the study
- Previously having any disease or skin problem causing hair loss
- Having received chemotherapy before
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 weeks
Participants receive weekly applications of coconut oil to the hair follicles or no intervention during their chemotherapy treatment. Alopecia is assessed weekly to monitor hair loss.
Weekly visits for up to 12 weeks
Trial Site Locations
Total: 1 location
1
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi
Ankara, Yenimahalle, Turkey (Türkiye), 06170
Actively Recruiting
Research Team
İ
İsmail Dakdevir, Nurse
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here